Eye-Tracking Alcohol Warning
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT07852013
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alcohol
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Alcohol Cancer Warning Labels — BEHAVIORALParticipants will be exposed to alcohol-cancer warning labels during two sequential study states. Stage 1 consists of Eye-Tracking Experiment in which participants will be exposed to six alcohol warning-label stimuli, including graphic alcohol cancer warning labels and Surgeon General text-only warning labels displayed on beer, wine, and liquor containers. Each participant will view all six warning-label stimuli for 15 seconds each in a randomized, counterbalanced order while visual attention is measured using eye-tracking technology. Stage 2 consist of the Discrete Choice Experiment in which participants will choose between 18 randomly presented choice sets. Choice sets will vary by warning label type, warning label size, and alcohol type (beer, wine, or liquor). Participants' responses will be used to assess preferences and behavioral reactions to different alcohol warning-label characteristics.
Study Details
This pilot study will evaluate communication strategies that may improve public understanding of alcohol-related cancer risks and influence behavioral intentions. The study will compare graphic alcohol cancer warning labels with the current U.S. Surgeon General text-only warning label across two stages. The first stage is an in-person, lab-based eye-tracking experiment that will examine differences in visual attention, communication outcomes, harm perception, and behavioral intentions following exposure to graphic versus text-only warning labels. The second stage is a discrete choice experiment that will examine how warning label type, warning label size, and alcohol type (beer, wine, or liquor) influence participants' intentions to reduce or stop alcohol consumption and purchase alcohol. The study will recruit 50 adults aged 21 years or older who report regular alcohol consumption.
Key Dates
- First listed
- Oct 1, 2026
- Start date
- Oct 31, 2026
- Status verified
- Sep 2026
- Primary completion
- Oct 1, 2027
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Alcohol Warning Label ExposureParticipants will complete a 2-stage behavioral experiment during a single study visit. Stage 1 Eye-Tracking Experiment: Participants will complete an eye-tracking experiment during which they will view six alcohol warning-label stimuli presented one at a time in a randomized, counterbalanced order. The stimuli include graphic and text-only warning labels displayed on beer, wine, and liquor containers. Stage 2 Discrete Choice Experiment: Following completion of the eye-tracking experiment, participants will complete a discrete choice experiment consisting of 18 randomly presented choice sets that vary by warning label type, warning label size, and alcohol type. Participants' responses will be used to assess preferences and behavioral reactions to different alcohol warning-label characteristics.
Primary Outcome Measure
Visual Attention Metrics [ Time Frame: During Stage 1 of the single study visit, approximately 35-45 minutes ]
Central Contacts
- Taghrid Asfar, MD, MSPH(305) 243-3826
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami - Rosenstiel Medical Science Building | Miami | Florida | 33136 | Olusanya Oluwole (SUB_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- Rapid BAC Reduction with Nutraceutical Blend StudyPHASE2 · Not Yet Recruiting · Medical Life Care Planners, LLC · St. Petersburg, Florida
- Testing Alcohol Cancer Risk MessagesEnrolling By Invitation · University of Miami · Miami, Florida
- Tirzepatide for Alcohol Use DisorderPHASE2 · Recruiting · University of Southern California · Los Angeles, California
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVPHASE2 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee